false 0000765880 0000765880 2024-04-25 2024-04-25 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 8-K 

 

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

April 25, 2024

Date of Report (Date of earliest event reported)

 

 

 

Healthpeak Properties, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Maryland 001-08895 33-0091377
(State or other jurisdiction of incorporation) (Commission File Number)

(IRS Employer Identification No.)

 

4600 South Syracuse Street, Suite 500

Denver, CO 80237

(Address of principal executive offices) (Zip Code)

 

(720) 428-5050

(Registrant’s telephone number, including area code)

 

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, $1.00 par value DOC New York Stock Exchange

 

 

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

 

 

Item  5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

(b)            Departure of Directors or Certain Officers

 

Christine N. Garvey and David B. Henry retired from the Board of Directors (the “Board”) of Healthpeak Properties, Inc. (the “Company”) effective immediately prior to the 2024 annual meeting of stockholders held on April 25, 2024 (the “Annual Meeting”). In connection with their retirements pursuant to the Company’s director term limit policy, the Board reduced its size from thirteen to eleven directors.

 

Item  5.07 Submission of Matters to a Vote of Security Holders.

 

At the Annual Meeting, there were present, in person or by proxy, 636,242,256 shares of the Company’s common stock, which represented approximately 89.66% of the shares entitled to vote and constituted a quorum.

 

Set forth below are the voting results for the three proposals considered and voted upon at the Annual Meeting, each of which were described in the Company’s definitive proxy statement on Schedule 14A, filed with the Securities and Exchange Commission on March 13, 2024.

 

Proposal 1. All of the nominees listed below were elected to the Board of Directors of the Company, each having received the affirmative vote of a majority of the votes cast.

 

   For   Against   Abstain  

Broker

Non-Votes

   % of Votes Cast Supporting 
Scott M. Brinker   582,831,626    4,068,380    479,750    48,862,500    99.31%
Katherine M. Sandstrom   553,781,817    33,118,908    479,031    48,862,500    94.36%
John T. Thomas   583,191,586    3,710,222    477,948    48,862,500    99.37%
Brian G. Cartwright   578,484,811    8,390,456    504,489    48,862,500    98.57%
James B. Connor   579,928,038    6,962,013    489,705    48,862,500    98.81%
R. Kent Griffin, Jr.   579,229,541    7,662,898    487,317    48,862,500    98.69%
Pamela J. Kessler   583,698,642    3,222,110    459,004    48,862,500    99.45%
Sara G. Lewis   566,873,595    20,035,240    470,921    48,862,500    96.59%
Ava E. Lias-Booker   583,544,342    3,331,289    504,125    48,862,500    99.43%
Tommy G. Thompson   582,923,497    3,962,088    494,171    48,862,500    99.32%
Richard A. Weiss   583,029,763    3,864,720    485,273    48,862,500    99.34%

 

Proposal 2. The advisory vote to approve 2023 executive compensation was approved.

 

For  Against   Abstain   Broker Non-Votes   % of Votes Cast
Supporting
 
548,270,776   38,235,408    873,572    48,862,500    93.48%

 

 

 

 

Proposal 3. The ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024, was approved.

 

For  Against   Abstain   Broker Non-Votes   % of Votes Cast
Supporting
 
620,953,588   14,829,272    459,396    N/A    97.67%

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: April 26, 2024 HEALTHPEAK PROPERTIES, INC.
 
  By: /s/ Jeffrey H. Miller
    Jeffrey H. Miller
    General Counsel